Can a gentler tooth treatment save painful baby molars?

NCT ID NCT07783217

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This trial compares two dental procedures for treating severe, irreversible pulpitis (nerve inflammation) in baby molars of healthy children. One group receives a pulpotomy using MTA, a less invasive procedure that removes only the infected pulp from the crown. The other receives a pulpectomy with Metapex, which removes the entire nerve. The study aims to see if the gentler pulpotomy can achieve similar clinical and radiographic success in preserving the tooth's function and health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MTA pulp dressing material (pulpotomy) compared to Metapex (pulpectomy)
What this could lead to
If MTA pulpotomy works as well as the more invasive pulpectomy, it could offer a simpler, less stressful treatment for children with severe tooth pain, potentially preserving baby teeth more comfortably.
What could go wrong
This is a single trial with 110 children, and results may not apply to all cases. Pulpotomy might not fully resolve severe pulp inflammation, and there's a risk of treatment failure requiring further procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 8 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * healthy and cooperative children * primary mandibular second molars with deep carious lesions and vital pulp * restorable crowns * history of spontaneous persistent lingering pain * normal radiographic appearance Exclusion Criteria: * clinical signs and symptoms of pulp necrosis * radiographic evidence of pathological root resorption

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Irreversible pulpitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Minia University Dental Hospita

    Minya, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.